MedPath

UNIVERSITY OF WASHINGTON

UNIVERSITY OF WASHINGTON logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private
Established
1861-01-01
Employees
10K
Market Cap
-
Website
https://www.cs.washington.edu

Clinical Trials

1.4k

Active:71
Completed:852

Trial Phases

6 Phases

Early Phase 1:9
Phase 1:127
Phase 2:208
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1193 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
700 (58.7%)
Phase 2
208 (17.4%)
Phase 1
127 (10.6%)
Phase 4
91 (7.6%)
Phase 3
58 (4.9%)
Early Phase 1
9 (0.8%)

The Effective of Immersive Virtual Reality Distraction on Memory: Study 1

Not Applicable
Completed
Conditions
Healthy Participants
First Posted Date
2025-09-15
Last Posted Date
2025-09-15
Lead Sponsor
University of Washington
Target Recruit Count
16
Registration Number
NCT07172230
Locations
πŸ‡ΊπŸ‡Έ

University of Washington, Seattle, Washington, United States

Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms

Not Applicable
Not yet recruiting
Conditions
Accelerated Phase Myeloproliferative Neoplasm
Blast Phase Myeloproliferative Neoplasm
Interventions
Other: Survey Administration
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
First Posted Date
2025-08-29
Last Posted Date
2025-08-29
Lead Sponsor
University of Washington
Target Recruit Count
27
Registration Number
NCT07148947
Locations
πŸ‡ΊπŸ‡Έ

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Integrating HIV Prevention With TB Household Contact Evaluation in Uganda

Not Applicable
Not yet recruiting
Conditions
Tuberculosis (TB)
Human Immunodeficiency Virus (HIV) Prophylaxis
First Posted Date
2025-08-13
Last Posted Date
2025-08-13
Lead Sponsor
University of Washington
Target Recruit Count
2480
Registration Number
NCT07119359
Locations
πŸ‡ΊπŸ‡¬

Infectious Diseases Institute, Kampala, Uganda

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

Not Applicable
Not yet recruiting
Conditions
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic HER2-Negative Breast Carcinoma
Metastatic Hormone Receptor-Positive Breast Carcinoma
Interventions
Biological: CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
Procedure: Computed Tomography
Drug: Cyclin-Dependent Kinase 4 Inhibitor
Drug: Cyclin-Dependent Kinase 6 Inhibitor
Procedure: Positron Emission Tomography
Procedure: Ultrasound Imaging
Procedure: Biopsy Procedure
Procedure: Biospecimen Collection
First Posted Date
2025-08-08
Last Posted Date
2025-09-10
Lead Sponsor
University of Washington
Target Recruit Count
40
Registration Number
NCT07112053
Locations
πŸ‡ΊπŸ‡Έ

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV

Not Applicable
Not yet recruiting
Conditions
HIV
Heart Failure
First Posted Date
2025-08-05
Last Posted Date
2025-08-05
Lead Sponsor
University of Washington
Target Recruit Count
30
Registration Number
NCT07105007
Locations
πŸ‡ΊπŸ‡Έ

University of Washington, Seattle, Washington, United States

πŸ‡§πŸ‡·

Londrina State University, Londrina, Parana, Brazil

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 272
  • Next

News

Lila Biologics Partners with Eli Lilly for AI-Driven Radioligand Therapy Development

Lila Biologics announced a global licensing and multi-target research collaboration with Eli Lilly focused on discovering and developing novel radioligand therapies for solid tumor imaging and treatment.

Novel Buprenorphine Protocol Eliminates Withdrawal Requirement for Opioid-Use Disorder Treatment

University of Washington researchers developed a new buprenorphine treatment protocol that allows patients to begin opioid-use disorder therapy without stopping fentanyl use or experiencing withdrawal symptoms.

Global Rheumatoid Arthritis Incidence Rises 13.2% Over Three Decades Despite Declining Mortality

Global rheumatoid arthritis incidence increased 13.2% from 1990 to 2021, affecting 17.9 million people worldwide by 2021, with significant regional disparities and a shift toward younger age groups.

Global Study Reveals Significant Gender Disparities in Health Outcomes

Men experience higher mortality rates from 13 of the top 20 global health conditions, with COVID-19 and heart disease showing 45% higher illness and death rates compared to women.

Stanford Researchers Develop Novel RNA Blood Test for Cancer Detection and Treatment Resistance Monitoring

Stanford Medicine researchers have developed a revolutionary blood test that analyzes cell-free RNA molecules to detect cancers at various stages, including early-stage lung cancer with 73% accuracy.

Breakthrough Diagnostic Tools for Early Fatty Liver Disease Detection: AI and Blood Tests Show Promise

New AI technology developed at University of Washington has identified hundreds of undiagnosed fatty liver disease cases by analyzing existing imaging scans, with 83% of patients with evidence of the disease lacking formal diagnosis.

Environmental Pollutants Significantly Increase Childhood Asthma Risk, New Studies Reveal

Recent research shows that ozone pollution exposure during a child's first two years increases asthma risk by 31% at ages 4-6, highlighting the need for long-term ozone regulation.

Wildfire Smoke Exposure Linked to Increased Dementia and Mental Health Risks, Studies Find

New research from Kaiser Permanente Southern California reveals wildfire smoke exposure significantly increases dementia risk, with each one-microgram-per-square-meter increase in wildfire-generated PM 2.5 associated with an 18% higher risk of dementia diagnosis.

Global Obesity Crisis Accelerating: 80% of Americans Projected to be Overweight or Obese by 2050

Four out of five Americans are projected to be overweight or obese by 2050, with obesity rates increasing faster than overweight, according to a comprehensive study published in The Lancet.

Experts Challenge Conventional Wisdom on Drug Launch Pricing Evaluations

New research identifies four critical limitations in comparing drug launch prices with value-based prices derived from conventional cost-effectiveness analyses, complicating policy decisions.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.